Axcella Health Inc. (AXLA)
Dec 29, 2023 - AXLA was delisted (reason: company dissolved)
0.4009
0.00 (0.00%)
Inactive · Last trade price on Dec 29, 2023

Axcella Health Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Axcella Health.

Price Target: n/a
Analyst Consensus: Hold
No price target forecast data available
TargetLowAverageMedianHigh
Pricen/an/an/an/a
Changen/an/an/an/a

Analyst Ratings

According to 1 stock analyst, the rating for Axcella Health is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

RatingSep '22Oct '22Nov '22Dec '22Jan '23Feb '23
Strong Buy222110
Buy221110
Hold100221
Sell000000
Strong Sell000000
Total543441

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Maintains
n/a
HoldMaintainsn/an/aFeb 16, 2023
SVB Leerink
SVB Leerink
Hold
Downgrades
$150$50
HoldDowngrades$150$50+12,371.94%Dec 16, 2022
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
n/a
HoldDowngradesn/an/aDec 15, 2022
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$175$125
Strong BuyMaintains$175$125+31,079.85%Nov 2, 2022
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$200$250
Strong BuyMaintains$200$250+62,259.69%Oct 3, 2022
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-5.10
from -1.52
EPS Next Year
-5.10
from -5.10
Year20182019202020212022202320242025
Revenue
--------
Revenue Growth
--------
EPS
-2.18-3.61-1.85-1.76-1.52-5.10-5.10-5.36
EPS Growth
--------
Forward PE
--------
No. Analysts
-----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202320242025
Highn/an/an/a
Avgn/an/an/a
Lown/an/an/a

Revenue Growth

Revenue Growth202320242025
High---
Avg---
Low---

EPS Forecast

EPS202320242025
High-5.25-5.25-5.51
Avg-5.10-5.10-5.36
Low-4.90-4.90-5.15

EPS Growth

EPS Growth202320242025
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.